Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome.

Qingguo Ruan | Vasumathi Kameswaran | Yukiko Tone | Li Li | Hsiou-Chi Liou | Mark I Greene | Masahide Tone | Youhai H Chen
Immunity | 2009

Regulatory T (Treg) cells are essential for maintaining immune homeostasis. Although Foxp3 expression marks the commitment of progenitors to Treg cell lineage, how Treg cells are generated during lymphocyte development remains enigmatic. We report here that the c-Rel transcription factor controlled development of Treg cells by promoting the formation of a Foxp3-specific enhanceosome. This enhanceosome contained c-Rel, p65, NFAT, Smad, and CREB. Although Smad and CREB first bound to Foxp3 enhancers, they later moved to the promoter to form the c-Rel enhanceosome. c-Rel-deficient mice had up to 90% reductions of Treg cells compared to wild-type mice, and c-Rel-deficient T cells were compromised in Treg cell differentiation. Thus, Treg cell development is controlled by a c-Rel enhanceosome, and strategies targeting Rel-NF-kappaB can be effective for manipulating Treg cell function.

Pubmed ID: 20064450

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: R56 AI050059
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI069289
  • Agency: NIAID NIH HHS, United States
    Id: AI069289
  • Agency: NIAID NIH HHS, United States
    Id: AI50059
  • Agency: NIDDK NIH HHS, United States
    Id: DK070691
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK070691
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK070691-03
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM085112
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI050059-06A2
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI050059
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM085112-02

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Miltenyi Biotec (tool)

RRID:SCR_008984

An Organization portal, Antibody supplier, Service resource,

View all literature mentions